Alexander J, Cukierman E. Cancer-associated fibroblast: mediators of tumorigenesis. Matrix Biol. 2020;91–92:19–34.

Article  PubMed  PubMed Central  Google Scholar 

Mori Y, Dendl K, Cardinale J, Kratochwil C, Giesel FL, Haberkorn U. FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease. Radiology. 2023;306(2):e220749.

Article  PubMed  Google Scholar 

Lan L, Liu H, Wang Y, Deng J, Peng D, Feng Y, et al. The potential utility of broad-spectrum oncological and non-oncological imaging agent. Eur J Nucl Med Mol Imaging. 2022;49(3):963–79.

Article  CAS  PubMed  Google Scholar 

Wei Y, Zheng J, Ma L, Liu X, Xu S, Wang S, et al. [18F]AlF-NOTA-FAPI-04: FAP-targeting specificity, biodistribution, and PET/CT imaging of various cancers. Eur J Nucl Med Mol Imaging. 2022;49(8):2761–73.

Article  CAS  PubMed  Google Scholar 

Wei Y, Cheng K, Fu Z, Zheng J, Mu Z, Zhao C, et al. [18F]AlF-NOTA-FAPI-04 PET/CT uptake in metastatic lesions on PET/CT imaging might distinguish different pathological types of lung cancer. Eur J Nucl Med Mol Imaging. 2022;49(5):1671–81.

Article  CAS  PubMed  Google Scholar 

Qiao K, Qin X, Fu S, Ren J, Jia J, Hu X, et al. Value of [18F]AlF-NOTA-FAPI-04 PET/CT for differential diagnosis of malignant and various inflammatory lung lesions: comparison with [18F]FDG PET/CT. Eur Radiol. 2024;34(3):1948–59.

Article  CAS  PubMed  Google Scholar 

Yang L, Xu S, Cheng L, Gao C, Cao S, Chang Z, et al. [18F]AlF-NOTA-FAPI-04 PET/CT as a promising tool for imaging fibroblast activation protein in gastrointestinal system cancers: a prospective investigation of comparative analysis with [18F]FDG. Eur J Nucl Med Mol Imaging. 2023;50(13):4051–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kou Y, Jiang X, Yao Y, Shen J, Jiang X, Chen S, et al. Physiological tracer distribution and benign lesion incidental uptake of Al18F-NOTA-FAPI-04 on PET/CT imaging. Nucl Med Commun. 2022;43(7):847–54.

Article  CAS  PubMed  Google Scholar 

Li Y, Gao J, Li Y, Duan X, Shen C. Non-specific uptake of [18F]FAPI-04 in the pancreas and its related factors: a post-hoc analysis of an ongoing prospective clinical trial. Sci Rep. 2024;14(1):11141.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lyu Z, Han W, Zhang Q, Zhao H, Liu S, Wang Y, et al. Clinical application of Al18F-NOTA-FAPI PET/CT in diagnosis and TNM staging of pancreatic adenocarcinoma, compared to [18F]FDG. Cancer Imaging. 2023;23(1):86.

Article  PubMed  PubMed Central  Google Scholar 

Li C, Tian Y, Chen J, Jiang Y, Xue Z, Xing D, et al. Usefulness of [68Ga]FAPI-04 and [18F]FDG PET/CT for the detection of primary tumour and metastatic lesions in gastrointestinal carcinoma: a comparative study. Eur Radiol. 2023;33(4):2779–91.

Article  CAS  PubMed  Google Scholar 

Chen J, Xu K, Li C, Tian Y, Li L, Wen B, et al. [68Ga]Ga-FAPI-04 PET/CT in the evaluation of epithelial ovarian cancer: comparison with [18F]F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2023;50(13):4064–76.

Article  CAS  PubMed  Google Scholar 

Çermik TF, Erg N, Erg F, Mercanog FG. Tumor imaging with 68Ga-DOTA-FAPI-04 PET/CT: comparison with 18F-FDG PET/CT in 22 different cancer types. Clin Nucl Med. 2022;47(4):333–9.

Article  Google Scholar 

Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, et al. Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47(8):1820–32.

Article  PubMed  Google Scholar 

Liu H, Yang X, Liu L, Qu G, Chen Y. Comparison of 18F-FDG and 68Ga-FAPI-04 uptake in postoperative re-evaluation of gastric, duodenal, and colorectal cancers. Clin Nucl Med. 2023;48(4):304–8.

Article  PubMed  Google Scholar 

Li X, Ma W, Wang M, Quan Z, Zhang M, Ye J, et al. 68Ga-FAPI-04 PET for surveillance of anastomotic recurrence in postoperative patients with gastrointestinal cancer: a comparative study with 18F-FDG PET. Mol Imaging Biol. 2023;25(5):857–66.

Article  PubMed  Google Scholar 

Li W, Jiang Z, Cui N, Li J, Cheng L, Liu W, et al. Superiority of FAPI-PET/CT for examining multiple malignant tumors: a retrospective study. Am J Cancer Res. 2023;13(10):4547–59.

CAS  PubMed  PubMed Central  Google Scholar 

Ding J, Qiu J, Hao Z, Huang H, Liu Q, Liu W, et al. Comparing the clinical value of baseline [68Ga]Ga-FAPI-04 PET/CT and [18F]F-FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitis. Eur J Nucl Med Mol Imaging. 2023;50(13):4036–50.

Article  CAS  PubMed  Google Scholar 

Hathi DK, Jones EF. 68Ga FAPI PET/CT: tracer uptake in 28 different kinds of cancer. Radiol Imaging Cancer. 2019;1(1):e194003.

Article  PubMed  PubMed Central  Google Scholar 

Xie Y, Tang W, Ma J, Chen Y. A retrospective study of (68)Ga-FAPI PET/CT in differentiating the nature of pulmonary lesions. Front Oncol. 2024;14:1373286.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma D, Zhang Y, Shao X, Wu C, Wu J. PET/CT for predicting occult lymph node metastasis in gastric cancer. Curr Oncol. 2022;29(9):6523–39.

Article  PubMed  PubMed Central  Google Scholar 

Polack M, Hagenaars SC, Couwenberg A, Kool W, Tollenaar R, Vogel WV, et al. Characteristics of tumour stroma in regional lymph node metastases in colorectal cancer patients: a theoretical framework for future diagnostic imaging with FAPI PET/CT. Clin Transl Oncol. 2022;24(9):1776–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Treglia G, Sadeghi R, Annunziata S, Lococo F, Cafarotti S, Prior JO, et al. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis. Lung Cancer. 2014;83(1):1–7.

Article  PubMed  Google Scholar 

Power JW, Dempsey PJ, Yates A, Fenlon H, Mulsow J, Shields C, et al. Peritoneal malignancy: anatomy, pathophysiology and an update on modern day imaging. Br J Radiol. 2022;95(1132):20210217.

Article  PubMed  Google Scholar 

Fu H, Wu J, Huang J, Sun L, Wu H, Guo W, et al. 68Ga fibroblast activation protein inhibitor PET/CT in the detection of metastatic thyroid cancer: comparison with 18F-FDG PET/CT. Radiology. 2022;304(2):397–405.

Article  PubMed  Google Scholar 

Mu X, Huang X, Jiang Z, Li M, Jia L, Lv Z, et al. [18F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with [18F]FDG PET/CT. Eur J Nucl Med Mol Imaging. 2023;50(4):1205–15.

Article  CAS  PubMed  Google Scholar 

Liu X, Yan S, Qin X, Cheng K, Zheng J, Wu H, et al. Increased 18F-FAPI uptake in bones and joints of lung cancer patients: characteristics and distributions. Skeletal Radiol. 2023;52(12):2377–86.

Article  PubMed  Google Scholar 

Shu Q, Deng M, Hu M, Liu M, Chen X, Chen Y, et al. The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG. Eur J Nucl Med Mol Imaging. 2023;50(5):1442–52.

Article  CAS  PubMed  Google Scholar